Technical Analysis for NVAX - Novavax, Inc.

Grade Last Price % Change Price Change
B 237.54 0.11% 0.27
NVAX closed up 0.11 percent on Friday, September 17, 2021, on 63 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical NVAX trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Bullish Engulfing Bullish 0.11%
Bollinger Band Squeeze Range Contraction 0.11%
NR7 Range Contraction 0.11%
Hammer Candlestick Bullish 2.26%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.26%
Bollinger Band Squeeze Range Contraction 2.26%
20 DMA Resistance Bearish 1.39%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.39%
Bollinger Band Squeeze Range Contraction 1.39%
Older End-of-Day Signals for NVAX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Novavax, Inc. Description

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines. Its vaccine candidates target seasonal influenza, pandemic (H5N1) influenza, and respiratory syncytial virus (RSV). The company, through its joint venture, CPL Biologics Private Limited, engages in developing seasonal and pandemic influenza, and rabies vaccine candidates. The company has a licensing agreement with LG Life Sciences, Ltd. to use the company's VLP technology to develop and sell the influenza vaccines in South Korea and other countries; and a clinical development agreement with PATH Vaccine Solutions to develop RSV vaccine candidate. The company was founded in 1987 and is headquartered in Rockville, Maryland.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Development Infectious Diseases Influenza Vaccine Coronavirus Vaccination Influenza Vaccine Influenza Vaccines Rabies Seasonal Influenza Novavax

Is NVAX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 331.5388
52 Week Low 76.59
Average Volume 4,891,935
200-Day Moving Average 191.69
50-Day Moving Average 220.79
20-Day Moving Average 242.80
10-Day Moving Average 246.31
Average True Range 16.65
ADX 14.98
+DI 22.66
-DI 23.29
Chandelier Exit (Long, 3 ATRs) 227.85
Chandelier Exit (Short, 3 ATRs) 266.72
Upper Bollinger Bands 267.68
Lower Bollinger Band 217.92
Percent B (%b) 0.39
BandWidth 20.50
MACD Line 4.46
MACD Signal Line 7.71
MACD Histogram -3.257
Fundamentals Value
Market Cap 15.12 Billion
Num Shares 63.7 Million
EPS -8.60
Price-to-Earnings (P/E) Ratio -27.63
Price-to-Sales 30.36
Price-to-Book 77.25
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 253.70
Resistance 3 (R3) 252.39 245.69 251.00
Resistance 2 (R2) 245.69 241.58 246.35 250.10
Resistance 1 (R1) 241.62 239.04 238.27 242.93 249.21
Pivot Point 234.92 234.92 233.25 235.58 234.92
Support 1 (S1) 230.85 230.81 227.50 232.16 225.87
Support 2 (S2) 224.15 228.27 224.81 224.98
Support 3 (S3) 220.08 224.15 224.08
Support 4 (S4) 221.39